Furoclav 1pcs

INDICATIONS
Furoclav® is indicated for the treatment of patients with mild to moderate infections
caused by susceptible strains of the designated microorganisms in the conditions
listed below:
Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus
influenzae (including beta-lactamase–producing strains), Moraxella catarrhalis
(including beta-lactamase–producing strains), or Streptococcus pyogenes.
Acute Bacterial Maxillary Sinusitis caused by Streptococcus pneumoniae or
Haemophilus influenzae (non-β-lactamase–producing strains only).
Acute Bacterial Exacerbations of Chronic Bronchitis and Secondary Bacterial
Infections of Acute Bronchitis caused by Streptococcus pneumoniae, Haemophilus
influenzae (β-lactamase negative strains), or Haemophilus parainfluenzae
(beta-lactamase negative strains).
Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus
aureus (including β-lactamase–producing strains) or Streptococcus pyogenes.
Uncomplicated Urinary Tract Infections caused by Escherichia coli or Klebsiella
pneumoniae.
Uncomplicated Gonorrhea, (urethral and endocervical) caused by penicillinaseproducing
and non-penicillinase–producing strains of Neisseria gonorrhoeae.
Early Lyme disease (erythema migrans) caused by Borrelia burgdorferi.

DOSAGE
Furoclav® Tablets: The usual course of therapy with Furoclav tablets is 5 to 7 days
for treatment of bronchitis, and 7 to 10 days for most other infections.
TABLE 1: Indications & dosage for Furoclav tablets (May be administered without regard to meals.)

PRECAUTIONS
Cefuroxime and Clavulanic acid combination should be given with caution to patients
receiving potent diuretics and who have a history of colitis.

Use in pregnancy & lactation
During pregnancy: While all antibiotics should be avoided in the first trimester if
possible. However, Furoclav can be safely used in later pregnancy to treat urinary and
other infections.
During lactation: Because Cefuroxime-clav is excreted in human milk, consideration
should be given to discontinuing nursing temporarily during treatment with
Cefuroxime.